Abstract: Rehabilitation systems and related methods are generally described. In some embodiments, a rehabilitation system may employ a flexible wearable robotic system which may be positioned on a user's appendage. The wearable robotic system may deform the appendage in a clinically relevant manner to facilitate rehabilitation of the appendage's motor function. In some embodiments, the wearable robotic system may include one or more sensors configured to measure the movement of the actuator based on its own actuation and/or the user's effort. The system may then convey such measurements to a processor for analysis and to a display to provide real-time feedback of the user's progress to the user and/or a clinician. In some embodiments, the actuator may be a glove.

Abstract: The present disclosure relates to a biomimetic lightweight wearable suit and wearable suit design method, particularly to a biomimetic lightweight wearable suit that includes a suit portion that covers a body region from the knee to the sole of the foot; a force transmission pattern portion that surrounds around joints and muscles by mimicking a tendon to disperse a force of an actuator to a garment and a body; and an anchor point portion that is designed to surround a joint by mimicking a ligament.

Abstract: Quadrantanopial occlusive lenses and method of use includes the steps of performing a vision zone assessment test to identify a field area of a patient's field of view having a selected characteristic, based on the identified field area, providing an appliance having a non-transparent optical characteristic associated with the field area, the patient wearing the appliance, and while the patient is wearing the appliance, the patient performing a selected activity associated with the neurological performance. The neurological performance may be associated with the quality of performance of the selected activity. The selected activity may be a physical activity. The step of performing a vision zone assessment test may include moving a visual target about the patient's field of view. The step of performing a vision zone assessment test may include observing the patient's eye movements in response to a moving visual stimulus.

Abstract: A patch can be configured for nonpermanent attachment to an exterior surface of a user wherein tissue can be disposed beneath the exterior surface. The patch can include a base defining opposing substantially planar surfaces, the substantially planar surfaces including a user engaging surface and an opposite surface. The user engaging surface can include an adhesive configured for non-permanent attachment to the user's exterior surface. The adhesive can be being configured to form a sufficiently strong bond with the user's exterior surface such that movement of the base causes movement of the tissue beneath the user's exterior surface. A handle can project from the opposite surface of the base in a direction away from the user engaging surface, the handle communicating with the base such that movement of the handle causes movement of the base.

Abstract: Provided is a massage device capable of forward and backward tilting, and the massage device may include: a main frame which supports at least a region of a user's body; a base frame which is disposed under the main frame and supports the main frame; a tilting frame which is disposed between the main frame and the base frame and is connected to tilting shafts provided at the front of the base frame to extend in the lateral direction; and a tilting means which is disposed between the base frame and the tilting frame and tilts the tilting frame around the tilting shafts.

Abstract: A massager for massaging limbs contains: an armrest including two accommodation cavities configured to receive two arms of a user, multiple air bags arranged on a top of a respective one accommodation cavity, and a driver fixed on a bottom of the respective one accommodation cavity. The driver includes a protective shell disposed on the armrest, at least one rotation disc arranged on the protective shell, a drive source, and a transmission mechanism. The drive source is connected with the at least one rotation disc via the transmission mechanism, and a respective one rotation disc includes multiple massage protrusions located outside the protective shell.

Abstract: The invention is directed to an erectile dysfunction treatment apparatus comprising: a pad adapted to contact a hind region of a patient, the pad including at least one acoustic wave actuator; a pouch connected to the pad, the pouch configured to wrap around the penile shaft, the pouch including at least one primary vibrating pad, and at least one primary LED; and a control unit electrically coupled to the at least one acoustic wave actuator, the at least one primary vibrating pad and the at least one primary LED, the control unit configured to provide first actuation signals to the at least one acoustic wave actuator for performing a neovascularization treatment and configured to provide second actuation signals to the at least one primary vibrating pad and the at least one primary LED for performing a vasodilation treatment.

Abstract: A balance rehabilitation apparatus is provided, including an audio stimulation unit, an electronic stimulation unit and a control unit. The audio stimulation unit includes two speakers, and the electronic stimulation unit includes a plurality of first electronic stimulation agents and two second electronic stimulation agents. Two of the plurality of first electronic stimulation agents correspond to cheeks of a user, two of the plurality of first electronic stimulation agents correspond to a cerebellum of the user, and the two second electronic stimulation agents correspond to two mastoid processes of the user. The control unit is electrically connected with the two speakers, the plurality of first electronic stimulation agents and the two second electronic stimulation agents and simultaneously controls the two speakers, the plurality of first electronic stimulation agents and the two second electronic stimulation agents to operate to increase the efficiency of balance rehabilitation.

Abstract: A method and device for controlling nausea, anxiety and stress. The device includes a wristwatch-like housing, electrical circuitry for generating electrical impulses of which low-frequency of which direct current (DC) electrical pulses are preferred, a metal ground plate, three adjustable metal contact points, indicator lights, function buttons on the housing, and a strap for securing the housing to the wrist. There may also be a screen display for visualizations of different functions. An internal processor controls all device functions and can optionally communicate via USB or short-range communications with a telephone App. The method allows simultaneous application of a pulse voltage output to acupuncture points H7, Lu9 and P6 (Buddha's Triangle). An alternate embodiment uses three permanent magnets to simultaneously stimulate the three points of Buddha's Triangle.

Abstract: A glass cartridge comprises a cylindrical body portion comprising an outer diameter Dc and an average sidewall thickness Tc, the cylindrical body portion having a first end and a second end opposite the first end; an opening at the first end of the cylindrical body portion; a shoulder extending radially inward from the second end of the cylindrical body portion; and a neck extending from the shoulder and comprising an outer neck diameter NOD that is less than the outer diameter Dc of the cylindrical body portion. The average wall thickness Tc is less than or equal to 0.85*s1, wherein s1 is a wall thickness of a standard glass cartridge defined by ISO 13926-1:2004 having an outer diameter d1 that is closer to the outer diameter Dc than the outer diameter d1 of any other standard glass cartridge defined by ISO 13926-1:2004.

Abstract: A closed system transfer device (CSTD) and vial assembly machine includes a linear travel assembly including a linear mount, and an actuator operably coupled to the linear mount. The linear mount is movable in an axial direction between a first position and a second position spaced from the first position. A CSTD fixture is configured to be removably coupleable to the linear mount. A vial mount is disposed adjacent to a portion of the linear travel assembly. A vial fixture is configured to be removably coupleable to the vial mount. The vial fixture is sized to hold a vial in axial alignment with a portion of the CSTD fixture when the vial fixture is coupled to the vial mount and the CSTD fixture is coupled to the linear mount. When the linear mount moves from the first position to the second position, the linear mount moves relative to the vial mount.

Abstract: A securable and trackable pill dispenser assembly, a system for tracking and administering medication with the pill dispenser assembly, and related methods are presented herein. The pill dispenser assembly can include a tamper resistant cartridge and a smart pill dispensing portion. The pill dispensing portion of the pill dispenser assembly can be configured to authenticate a patient to the pill dispenser assembly and dispense medication according to a prescription accessible to the dispenser portion. The patient may be able to separate the cartridge from the dispenser portion at the end of a prescription period and mate a new cartridge to the dispenser portion for a new prescription period. The cartridge can be filled by a dispensing pharmacy and/or a pharmaceutical partner and delivered to the patient. The cartridge can inhibit extraction of medication when not mated to the dispensing portion.

Abstract: A method, a computer program product and a dispensing device for dispensing discrete medicaments, wherein the dispensing device comprises a dispensing section, a collection section and a packaging section, wherein the dispensing section defines an array of feeder positions for holding a plurality of feeder units, wherein the collection section comprises a first collection unit that is movable in a collection direction, wherein the method comprises the steps of: positioning a first feeder unit at a first feeder position; and prior to removing the first feeder unit from the first feeder position, positioning a second feeder unit at a second feeder position, downstream from the first feeder position in the collection direction, wherein the first feeder unit and the second feeder unit hold medicaments of the same first composition.

Abstract: An acoustic instrument soother for infants and young children, combining a pacifier, a teether, and a mouthguard with a harmonica to generate sound. The device incorporates non-electronic musical elements, aiming to soothe and entertain young users while fostering early musical education. The harmonica component features multiple mouthpieces for sound production, activated by the user's inhalation and exhalation. Through the integration of music notation symbols engraved on its surface, the device provides vocal and music notation lessons, enhancing the user's auditory and cognitive development.

Abstract: The invention relates to a dental composition provided as a kit of parts comprising a base paste and an initiator paste, the base paste comprising, a cationically curable pre-polymer comprising a backbone and at least two aziridine moieties, filler, the initiator paste comprising an initiator being able to start the hardening of the polyether pre-polymer, filler, optionally diluent, the base paste or the initiator paste or the base paste and the initiator paste comprising in addition an isosorbide component. The invention also relates to a process of taking an impression of dental tissue.

Abstract: Acylthiourea oligomers according to the formula The acylthiourea oligomers, in combination with a hydroperoxide compound, are active as initiators for the radical polymerization. Radically polymerizable compositions comprising at least one acylthiourea, at least one hydroperoxide and at least one radically polymerizable monomer are particularly suitable as dental materials.

Abstract: The present invention relates to an esthetic, robust, hybrid, biomimetic and fast grindable and printable dental composition containing an inorganic material in the form of platelets, and an organic material. The invention also relates to dental restorations made from the dental compositions.

Abstract: A method for masking the appearance of a support structure underlying a highly translucent ceramic dental restoration is provided. The porous form of a zirconia ceramic dental restoration is treated with a liquid masking composition comprising 0.4 wt % to 50 wt % of one or more masking agents. The masking composition is applied to the internal surface of a restoration and a region of the facial surface of the restoration that is opposite the internal surface. After application of the masking compositions, treated zirconia restoration is sintered to greater than 98% theoretical density.

Abstract: A product includes at least one first composition and at least one second composition: the first composition is a solid composition comprising at least one cavity such that the composition has porosity greater than or equal to 20% by volume relative to the total volume of the solid composition; the second composition is a liquid composition, preferably in the form of a cream, and advantageously having viscosity higher than 5000 cps, and wherein all or part of the second composition is housed in all or part of the cavities of the first composition.

Abstract: Method and composition for making up the lips. Method includes applying to the lips an anhydrous composition. The composition includes at least one nonvolatile silicone oil; at least one volatile oil; at least one film-former; at least one colorant; at least one platy mineral; and a mattifying agent. The at least one nonvolatile silicone oil and the at least one volatile oil are present in a weight ratio of nonvolatile silicone oil to volatile oil from about 4:1 to about 10:1.

Abstract: The invention is directed to a hydratable concentrated surfactant composition. The composition is pourable, easy to dilute, substantially free of sulfate and oil, comprises a C6-C14 acid, alcohol, amide or mixture thereof, anionic surfactant and an amphoteric surfactant, zwitterionic surfactant or both. The composition is in lamellar phase and thickens and transforms to an isotropic phase upon dilution. The composition comprises a hydroxyfunctionalized compound, can be used as a concentrate in small volumes and diluted as used and needed or can be diluted with water in refill packaging to ensure a reduction in plastic waste.

Abstract: Disclosed is a dry shampoo spray foam product having reduced volatile organic compound (VOC) content and low global warming potential as well as associated methods of use of such products. In one practice, the product comprises a dry shampoo spray foam composition of specific formulation in combination with a value actuator assembly having specific orifice size parameters.

Abstract: A water-in-silicone cosmetic composition is disclosed. The water-in-silicone cosmetic composition contains a water- or silicone-poorly soluble substance. Specifically, the water-in-silicone cosmetic composition can contain a high content of a substance that is poorly soluble in water or silicone by stably dispersing the substance in a silicone phase or aqueous phase, and has excellent long-term stability.

Abstract: Provided is a water-in-oil type solid emulsified cosmetic preparation with good feelings from use. The water-in-oil type solid emulsified cosmetic preparation, contains, and being substantially free of silicone compounds, a compound which is pasty at 25° C.; a compound selected from PEG-30 dipolyhydroxystearate, PEG-5 hydrogenated castor oil, PEG-10 hydrogenated castor oil, PEG-20 hydrogenated castor oil, PEG-30 hydrogenated castor oil, PEG-40 hydrogenated castor oil, PEG-60 hydrogenated castor oil and a combination of these; a solid oil component having a melting point of 65° C. or more; a low-viscosity liquid oil component having a viscosity of 40 mPa·s or less at 25° C.; and water.

Abstract: Nanoemulsions as emulsion additives are prepared to stabilize actives and prevent formulation discoloration. The nanoemulsions have at least 30% by weight oil and are suitable to add to emulsions and/or structured water to produce color stable end use skin benefit compositions.

Abstract: A dermatological topical agent, including granular gel capsules and a liquid. The granular gel capsules include a non-volatile oil agent, and the liquid includes a volatile medium. The granular gel capsules are dispersed in the liquid. A content of the non-volatile oil agent in the granular gel capsules is 1.5 mass % or more based on a total mass of the dermatological topical agent, a content of the non-volatile oil agent in the liquid is 0 mass % or more and 14 mass % or less based on the total mass of the dermatological topical agent, and a content of an aqueous thickener in the liquid is 0 mass % or more and 0.25 mass % or less based on the total mass of the dermatological topical agent.

Abstract: A method of manufacture of an aluminium-zirconium (Al/Zr) antiperspirant active comprising the heating in aqueous solution of an aluminium-zirconium tri-tetra- or penta-chlorohydrex-glycine complex and a water-soluble calcium salt, the molar ratio of aluminium to calcium being from 1.3 to 60.

Abstract: An aqueous composition comprising an aluminium-zirconium-glycine complex which is an aluminium-zirconium tri-, tetra-, or penta-chlorohydrex-glycine complex and a water-soluble calcium salt, the molar ratio of aluminium to calcium being from 1.3 to 60 and the molar ratio of aluminium to glycine being from 1.5 to 25.

Abstract: The invention relates to an eco-biological, lipo-alcoholic topical disinfectant composition that is virucidal, where appropriate bactericidal and/or yeasticidal, by friction and without rinsing, capable of regenerating the skin lipid barrier and perfectly well tolerated by the skin, including during repeated daily intensive use, characterized in that it comprises: at least 65% w/w of a C1-C8 alcohol; at least 10% by total weight of the composition of an oily phase comprising at least one component chosen from the list of the following components: plant oils, mineral oils, silicone oils, butters, esters, plant waxes, mineral waxes, silicone waxes, fatty acids, and fatty alcohols with fatty chains of more than 10 carbon atoms in length.

Abstract: The present invention relates to a transparent water-in-oil-type lip cosmetic composition comprising 2-10 wt % of water, 28-55 wt % of glycerin, and an oil phase, with respect to the total weight of the composition, and 50 wt % or more of octyldodecanol with respect to the total weight of the oil phase. The composition of the present invention has transparent appearance, thus imparting an aesthetic effect to products and at the same time, can impart gloss when applied onto lips, and can provide moisturization through the supply of moisture, and long-lasting coloring effect.

Abstract: The present invention relates to a cosmetic composition for treating keratin fibres, in particular human keratin fibres such as the hair, comprising at least propane-1,3-diol in a content as defined hereinafter, at least one alkanolamine in a content as defined hereinafter, at least one fatty substance, and at least one oxidation dye. The present invention also relates to a process for dyeing keratin fibres, such as the hair, in which the composition as described previously, and comprising at least one dye, preferably chosen from oxidation dyes, is applied to said fibres. The present invention also relates to the use of the composition according to the invention for dyeing keratin fibres such as the hair.

Abstract: Cosmetic product of a) a packaging of high-density polyethylene (HDPE), low-density polyethylene (LDPE), polypropylene (PP) or polyethylene terephthalate (PET), and b) a cosmetic preparation containing propylene glycol diester.

Abstract: The present invention relates to a composition for treating keratin fibres, notably human keratin fibres such as the hair, comprising at least one alkyl (poly)glycoside, N,N-dicarboxymethylglutamic acid, one of its salts, solvates and/or solvates of its salts, propane-1,3-diol, at least one fatty substance other than fatty acids, at least one dye. The present invention also relates to a process for dyeing keratin fibres, such as the hair, in which the composition as described previously is applied to said fibres. The present invention also relates to the use of the composition according to the invention for dyeing keratin fibres such as the hair.

Abstract: The present invention relates to a cosmetic composition for treating keratin fibres, notably human keratin fibres such as the hair, comprising N,N-dicarboxymethylglutamic acid, and/or salts thereof, solvates thereof and/or solvates of the salts thereof, 1,3-propanediol, at least one nonionic-surfactant chosen from (C6-C24 alkyl)polyglycosides, esters of C8-C30 fatty acids and of (poly)oxyalkylenated glycerol ethers, in particular of oxyethylenated and/or oxypropylenated glycerol ethers, and mixtures thereof, at least one alkaline agent and/or at least one dye. The present invention also relates to a process for dyeing and/or lightening keratin fibres, such as the hair, in which a composition comprising N,N-dicarboxymethylglutamic acid, and/or salts thereof, solvates thereof and/or solvates of the salts thereof, 1,3-propanediol, at least one nonionic surfactant, at least one alkaline agent and/or at least one dye is applied to said fibres.

Abstract: Silicone-free hair care compositions contain trimethylglycine, esterquats, and mono-, di- and triglycerides of vegetable oils in a cosmetic carrier, which are suitable for improving the care properties of hair, in particular for improving the sensory properties as well as the resistance of hair to physical damage.

Abstract: An object of the present invention is to provide a method for easily and efficiently evaluating the ability of test samples to trigger a foreign body reaction in the skin without using animals, a substance having an ability to inhibit a foreign body reaction in the skin, and a screening method for obtaining the substance.

Abstract: The present invention relates to a composition for treating keratin fibres, notably human keratin fibres such as the hair, comprising at least one (C14-C30)alkyl (poly)glycoside, at least one fatty alcohol, at least one fatty acid, at least one alkaline agent and optionally at least one dye chosen from oxidation dyes, direct dyes and mixtures thereof. The present invention also relates to a process for dyeing and/or lightening keratin fibres, such as the hair, wherein the composition as described previously is applied to said fibres. The present invention also relates to the use of the composition according to the invention for dyeing and/or lightening, preferably dyeing, keratin fibres such as the hair.

Abstract: The present invention belongs to the technical field of daily-use chemicals, and discloses a ginsenoside-containing composition, which includes the following components in parts by weight: 0.001-0.05 parts of palmitoyl tetrapeptide-7, 0.001-0.05 parts of blue copper peptide, 0.1-5 parts of ectoin, and 0.05-5 parts of a ginsenoside composition. According to the present invention, excellent fast acting and consistently-increased hair growth, hair loss prevention and hair development effects are achieved through preferred compounding of the ginsenoside composition and multiple polypeptides, etc. Meanwhile, the present invention further provides use of the composition and a daily-use chemical using the composition.

Abstract: So as to provide a hair growth agent which is a topical agent that exhibits effect in terms of causing increase in hair shaft diameter and improving maximum hair shaft length and improving hair shaft elongation rate and new hair growth and increasing expression of genes contributing to hair growth in dermal papilla cells and promoting hair shaft growth at head hair, beard, eyelashes, eyebrows, and/or other such hair, palmitoyl dipeptide-5 diaminobutyloyl hydroxythreonine, palmitoyl dipeptide-5 diaminohydroxybutyrate, and phytosphingosine are made to be contained therein as active ingredients, or palmitoyl dipeptide-5 diaminobutyloyl hydroxythreonine and palmitoyl dipeptide-5 diaminohydroxybutyrate are used in combination therein.

Abstract: To provide a hair growth agent which is a topical agent that exhibits effect in terms of causing increase in hair shaft diameter and improving maximum hair shaft length and improving hair shaft elongation rate and new hair growth and increasing expression of genes contributing to hair growth in dermal papilla cells and promoting hair shaft growth at head hair, beard, eyelashes, eyebrows, and/or other such hair, phytosphingosine and adenosine are both made to be contained as active ingredients in a hair growth agent, and/or phytosphingosine and/or adenosine are used in combination as active ingredients in a hair growth agent.

Abstract: So as to provide a hair growth agent which is a topical agent that exhibits effect in terms of causing increase in hair shaft diameter and improving maximum hair shaft length and improving hair shaft elongation rate and new hair growth and increasing expression of genes contributing to hair growth in dermal papilla cells and promoting hair shaft growth at head hair, beard, eyelashes, eyebrows, and/or other such hair, phytosphingosine and minoxidil are both made to be contained as active ingredients in a hair growth agent, and/or phytosphingosine and/or minoxidil are used in combination as active ingredients in a hair growth agent.

Abstract: A body milk for improved skin moisture level comprises hyaluronic acid and/or salts thereof. PEG-40 Sorbitan Perisostearate and Polyglyceryl-3 Diisostearate and Tocopherol, and one or more lipids selected from isopropyl palmitate, isododecane, almond oil, the preparation being free of BHT.

Abstract: An aqueous conditioning composition comprising: i) 0.1 to 2 of a cationic conditioning polymer; ii) 0.1 to 5 of an anionic surfactant comprising EO groups, with a degree of ethoxylation of from 3 to 15: wherein the composition has a transparency such that the turbidity is lower than 1 cm-1, as measured using a UV/vis spectrophotometer and applying the equation Turbidity=(2.3×A/L), where A is the absorbance measured from the sample at 750 nm and L is the path length, typically 1.

Abstract: A body milk for improved skin moisturization comprises hyaluronic acid and/or salts thereof, diisostearoyl polyglyceryl-3 dimer dilinoleate, polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate, tocopherol, and one or more lipids selected from isopropyl palmitate, isododecane, almond oil (Prunus amygdalus dulcis oil), sunflower oil (Helianthus annuus seed oil), coco-caprylate/caprate, Butyrospermum parkii butter. The preparation is free of BHT.

Abstract: A composition is described for use in preparing human nail applications, the composition comprising: a polymer component formed from: a first (meth)acrylate ester with an alkyl side chain of 3 or less carbon atoms; a second (meth)acrylate ester with a primary, secondary or tertiary alkyl side chain of at least 5 carbon atoms; and an initiator; or alternatively, (i) a polymer component formed from: a first (meth)acrylate ester with an alkyl side chain of 3 or less carbon atoms; and a second (meth)acrylate ester with a primary, secondary or tertiary alkyl side chain of at least 5 carbon atoms; and an initiator, in combination with (ii) a monomer component comprising: a first (meth)acrylate ester, where the (meth)acrylate ester is di-, tri-, or multi-functional; a second (meth)acrylate ester with an alkyl side chain of 3 or less carbon atoms; and an accelerator. A kit containing the composition and a method for preparing the composition are also described.

Abstract: The present invention relates to a cosmetic composition comprising: a) at least one anionic surfactant; b) at least one amphoteric or zwitterionic surfactant; c) at least one oil-in-water emulsion having a particle size D50 of less than 350 nm, the size being expressed on a volume basis, and comprising: —a silicone mixture comprising (i) one or more polydialkylsiloxanes bearing trialkylsilyl end groups, having a viscosity at 25° C. ranging from 40000 to 100000 mPa·s and (ii) one or more amino silicones having a viscosity at 25° C. ranging from 1000 to 15 000 mPa·s and an amine number ranging from 2 to 10 mg of KOH per gram of amino silicone; —a surfactant mixture comprising one or more nonionic surfactants, said mixture having an HLB ranging from 10 to 16; and—water; and d) at least 0.01% by weight, relative to the total weight of the composition, of one or more agents chosen from fatty amines, fatty acids, fatty alcohols and mixtures thereof.

Abstract: A skin care composition that includes water lily extract, lactobionic acid, and a dermatologically acceptable carrier. The skin care composition can inhibit yellowness by greater than 50% and inhibits % glycation by greater than or equal to 35% according to the Advanced Glycation End Product Assay.

Abstract: In some embodiments, soothing redness correction formulations are provided. In other embodiments, formulations to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. In yet other embodiments, certain formulations are renewal formulations adapted to treat the eye area to, for example, reduce laxity, puffiness, wrinkles and/or dark circles around the eye.

Abstract: Skin care formulations that function via a multi-modal approach are provided in some embodiments in which select ingredients work together to protect skin from ultraviolet light, hydrates the skin and provides antioxidant properties.

Abstract: The present invention relates to the formulation and the use of a cannabinoid, hyaluronate and certain botanical extracts or phytochemical materials to improve the health of skin. The formulations address the incompatibility between oil-soluble cannabinoids and aqueous herbal extracts, or water-soluble phytochemical components. Preferably, the botanical extract is selected from Opuntia ficus-indica, Carica papaya, Vasconcellea pubescens, Salvadora persica, Nigella sativa, Glycyrrhiza glabra, Camellia sinensis, and Aloe vera.